GlobalData on MSN13h
EU set to approve AstraZeneca’s Imfinzi-chemo combo for NSCLC
AstraZeneca's Imfinzi (durvalumab) plus chemotherapy combo has received the European Medicines Agency’s (EMA) Committee for ...
PMLiVE13h
J&J receives three CHMP recommendations for immunology and oncology indications
Tremfya, Stelara and Darzalex have been recommended for ulcerative colitis, Crohn’s disease and multiple myeloma, ...
Pharmabiz17h
Vertex Pharma receives CHMP positive opinion for label expansion of Kaftrio in combination with ivacaftor
Vertex Pharma receives CHMP positive opinion for label expansion of Kaftrio in combination with ivacaftor: London Tuesday, March 4, 2025, 14:00 Hrs [IST] Vertex Pharmaceuticals, a ...
PharmiWeb12h
Imfinzi-based perioperative regimen recommended for approval in the EU by CHMP for resectable non-small cell lung cancer
AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been recommended for approval in the European Union (EU) for the treatment of adults with resectable non-small cell lung cancer ...
Pharmabiz18h
EMA committee recommends approval of AstraZeneca’s Imfinzi in combo with chemotherapy to treat resectable non-small cell lung cancer
EMA committee recommends approval of AstraZeneca’s Imfinzi in combo with chemotherapy to treat resectable non-small cell lung cancer ...
Eisai Receives Regulatory Review Outcome For Lecanemab As A Treatment For Early Alzheimer's Disease In Australia
Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer's Disease in Australia TOKY ...
WABE3h
Decade after Georgia lawmakers legalized low-THC medical cannabis, Legislature weighs broader access
Ten years after Georgia legalized cannabis possession for medical use, lawmakers in both chambers of the state Legislature ...
Marijuana Moment7h
Georgia Lawmakers Weigh Broader Access To Medical Marijuana, Potentially Expanding Limited Low-THC Program
A lot of people still choose to go to the legacy market, the black market, or to even just order their hemp products online.” ...
Trump’s FDA pick made his name by bashing the medical establishment. Soon he may be leading it
Food and Drug Administration nominee Dr. Marty Makary is known for his contrarian views and fiery criticism of traditional ...
U.S. FDA places clinical hold on BioNTech's malaria vaccine study
BioNTech said in a regulatory filing on Tuesday the U.S. Food and Drug Administration has placed a clinical hold on an ...
BALVERSA Adoption On The Rise: Meeting Unmet Needs In Advanced Urothelial Cancer | Delveinsight
BALVERSA (erdafitinib) has strong market potential in the FGFR-altered urothelial carcinoma space, particularly as a targeted therapy for patients wi ...